Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Invested Capital (2020 - 2025)

NeuroPace has reported Invested Capital over the past 6 years, most recently at $77.9 million for Q4 2025.

  • Quarterly results put Invested Capital at $77.9 million for Q4 2025, up 15.36% from a year ago — trailing twelve months through Dec 2025 was $77.9 million (up 15.36% YoY), and the annual figure for FY2025 was $77.9 million, up 15.36%.
  • Invested Capital for Q4 2025 was $77.9 million at NeuroPace, up from $77.3 million in the prior quarter.
  • Over the last five years, Invested Capital for NPCE hit a ceiling of $138.0 million in Q2 2021 and a floor of -$152.3 million in Q1 2021.
  • Median Invested Capital over the past 5 years was $78.0 million (2025), compared with a mean of $77.1 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 195.65% in 2021 and later fell 28.91% in 2022.
  • NeuroPace's Invested Capital stood at $123.4 million in 2021, then fell by 28.91% to $87.7 million in 2022, then dropped by 11.5% to $77.6 million in 2023, then dropped by 12.98% to $67.5 million in 2024, then rose by 15.36% to $77.9 million in 2025.
  • The last three reported values for Invested Capital were $77.9 million (Q4 2025), $77.3 million (Q3 2025), and $78.1 million (Q2 2025) per Business Quant data.